Table 1.
Overview of Hormonal Contraception Formulations Available in United States 2008
| Oral Triphasic Formulation | ||
|---|---|---|
| Estrogen/ Progestin* | Dose | Brand/Trade Name |
| ethinyl estradiol/desogestrel | 25 mcg/0.1,0.125,0.15 mg | Cyclessa |
| ethinyl estradiol/levonorgestrel | 30 mcg/0.05mg, 40mcg/0.075mg, 30mcg/0.125mg | Enpresse, Trivora |
| ethinyl estradiol/norgestimate | 25 mcg/0.18,0.215,0.25 mg | Ortho Tri-Cyclen Lo |
| 35 mcg/0.18,0.215,0.25 mg | Ortho Tri-Cyclen, Tri-Previfem, Tri-Sprintec, TriNessa | |
| ethinyl estradiol/norethindrone | 35 mcg/0.5,0.75,1 mg | Necon 7/7/7, Ortho-Novum 77/7/7 Aranelle, Tri-Norinyl |
| 35 mcg/0.5,1,0.5 mg | ||
| Oral Monophasic Formulation | ||
|---|---|---|
| Estrogen/ Progestin† | Dose | Brand/Trade Name |
| ethinyl estradiol/levonorgestrel | 20 mcg/0.09 mg | Lybrel |
| 20 mcg/0.1 mg | Alesse, Aviane, Lutera | |
| 30 mcg/0.15mg | Jolessa, Levora, Nordette, Portia, Quasense, Seasonale§ | |
| 30mcg/0.15mg, 10mcg/0mg | Seasonique§ | |
| ethinyl estradiol/ desogestrel | 30 mcg/0.15 mg | Apri, Desogen, Reclipsen, |
| ethinyl estradiol/norethindrone | 20 mcg/1 mg‡ | Junel 21 1/20, Loestrin 21 1/20, Loestrin 24 Fe 1/20‡, Microgestin 1/20, Microgestin Fe 1/20 |
| 30 mcg/1.5 mg | Junel 21 1.5/30, Loestrin 21 1.5/30, Loestrin Fe 1.5/30, Microgestin 1.5/30, Microgestin Fe 1.5/30 | |
| 35 mcg/0.4 mg | Balziva, Femcom Fe, Ovcon35 | |
| 35 mcg/0.5 mg | Brevicon, Modicon, Necon 0.5/35 | |
| 35 mcg/1 mg | Necon 1/35, Norinyl 1/35, Ortho-Novum 1/35 | |
| 50 mcg/1 mg | Necon 1/50, Ovcon 50 | |
| ethinyl estradiol/norgestrel | 30 mcg/0.3 mg | Cryselle, Lo/Ovral, Low-Ogestrel |
| ethinyl estradiol/norgestimate | 35 mcg/0.25 mg | MonoNessa, Ortho-Cyclen, Previfem, Sprintec |
| mestranol/norethindrone | 50 mcg/1 mg | Norinyl 1/50 |
| ethinyl estradiol/drospirenone | 20 mcg/3 mg‡ | Yaz |
| 30 mcg/3 mg | Ocella, Yasmin | |
| ethinyl estradiol/ethynodiol | 35 mcg/1 mg | Kelnor, Zovia 1/35 |
| 50 mcg/1 mg | Zovia 1/50 | |
| ethinyl estradiol/desogestrel | 30mcg/0.15 mg | Ortho-Cept |
| Non-Oral Combined Formulations | ||
|---|---|---|
| Transdermal Estrogen/Progestin | Dose | Brand/Trade Name |
| ethinyl estradiol/norelgestromin | 20mcg/0.15mg/day patch | Ortho Evra |
| Vaginal Ring Estrogen/Progestin | Dose | Brand/Trade Name |
|---|---|---|
| ethinyl estradiol/etonogestrel vaginal | 15mcg/0.12mg/day vaginal ring | NuvaRing |
| Progestin only | ||
|---|---|---|
| Oral Progestin only | Dose | Brand/Trade Name |
| norethindrone | 0.35 mg | Camilla, Errin, Jolivette, Nor-QD, OrthoMicronor, Ovrette |
| Progestin injection | Dose | Brand/Trade Name |
|---|---|---|
| medroxyprogesterone acetate | 150mg, intramuscular, every 3 months | Depo-Provera |
| 104mg, subcutaneous, every 3 months | Depo-SubQ Provera | |
| Progestin releasing IUD | Dose | Brand/Trade Name |
|---|---|---|
| levonorgestrel | 52 mg IUD, daily release 20mcg | Mirena |
*
21 active tablets and 7 placebo, active tablets divided into 7 tablet doses as indicated.
†
21 active tablets and 7 placebo, active tablets are all same dose
‡
24 active tablets and 4 placeb
§
91-day extended formulation available with 84 consecutive active tablets and 7 placebo or 10mcg estradiol